Biologic Contract Manufacturing WebinarPosted on May 28, 2024 |
 |
June 6, 2024, 10:00 a.m. – 12:00 p.m. EST
Michael Hausladen, PhD, General Manager,
LOTTE Biologics
Register in advance for this meeting here.
After registering, you will receive a confirmation email.
Michael Hausladen is the General Manager for LOTTE Biologics USA, LLC, headquartered in Syracuse, NY. LOTTE Biologics is a Contract Development and Manufacturing Organization that is serving the biologic pharmaceutical market. Previous roles at Bristol Myers Squibb (BMS) included starting up the Devens, MA $350M Cell Therapy Facility, managing clinical external biologics manufacturing and various leadership roles including Director of Manufacturing and Director of Manufacturing Technology.
Prior to working in biologics, Michael worked at BMS scaling up and commercialization of enzyme catalyzed and traditional organic synthesis of active pharmaceutical ingredients. Michael has a PhD in chemical engineering from the University at Buffalo.
Other Network News
October 2, 2026SOS Supports YMCA Healthy Aging Day, Promoting Balance, Stability and Independence in the CommunitySyracuse Orthopedic Specialists (SOS) is proud to sponsor the YMCA of Central New York’s Healthy Aging Day on October 7, an event focused on helping adults stay active, connected and engaged. |
October 1, 2026Turning Stone’s New Luxury Hotel, The Crescent, Recognized as Top Casino Hotel in America by AAA Diamond ProgramThe honor comes just months after The Crescent opened its doors and weeks after Turning Stone’s transformation into New York’s largest meetings and conventions resort with the 225,000 square foot The Grand Expo. |
